HQE II Medicines Formulary 2022 has been updated based on Pekeliling/Tambahan kepada Formulari Ubat KKM bil 2/2022 (Bahagian 2) 4 Nov 2022

HQE II Medicines Formulary 2023 has been updated based on Pekeliling/Tambahan kepada Formulari Ubat KKM bil 3/2022 (23 Dec 2022).

Somatropin 6mg solution for injection, Desmopressin 120mg sublingual tablet, Polymyxin B 500,000iu injection & Omeprazole 40mg injection have been approved from the Mesyuarat Jawatankuasa Ubat & Terapeutik bil 1/2023 and added to this formulary.

Linezolid 600mg tablet (Medical Department) & Insulin Lispro 50% & Insulin Lispro Protamine 50% 100U/ml Suspension for Injection in Prefilled Syringe/Cartridge (Humalog Mix 50) have been  approved in the Mesyuarat Jawatankuasa Ubat & Terapeutik bil 2/2023.

While every effort has been made to ensure that the information contained in the HQE II Medicines Formulary is accurate and valid up to the time of publishing, errors and omissions may be expected. Please be advised that the formulary is updated periodically and changes may appear prior to the effective date.

Ceftazidime 2g & Avibactam 0.5g Injection (Medical Department - ID) and Methylene Blue 0.5% Injection (Surgical Department) have been approved in the Mesyuarat Jawatankuasa Ubat & Terapeutik bil 3/2023. 

The following drugs approved in the Mesyuarat JKUT bil 1/2024:
i) Ganciclovir sodium 50mg/ml injection (Medical Department - ID)
ii) Tocilizumab 20mg/ml injection (Medical Department - ID)
iii) Minocycline 100mg capsule (Medical Department - ID)
iv) Micafungin sodium 50mg injection (Medical Department - ID)
v) Idarucizumab 50mg/ml solution for injection/infusion (Cardiology)

The following drugs approved in the Mesyuarat JKUT bil 1/2024:
vi) Perindopril Arginine 10mg, Indapamide 2.5mg & Amlodipine 10mg Tablet (Endocrine)
vii) Pre/Post Natal Vitamin & Mineral Capsule: Zincofer (Standard)
viii) Somatropin 12mg injection (Endocrine)

The following drugs approved in the Mesyuarat JKUT bil 2/2024 on 11 July 2024:
i) Warfarin Sodium 3mg Tablet
ii) Valganciclovir 450mg Tablet

The following drug has been approved in the Mesyuarat JKUT bil 3/2024 on 10 October 2024: Insulin Glulisine 100u/ml solution for injection in pre-filled pen

A* = Consultant/Specialist from disciplines related to the listed indication only;
A = Consultant/Specialist;
A/KK = Consultant/Specialist/Family Physicians Specialist; 
B = Medical Officer;
C = Paramedical Staff;
C+ = Paramedical Staff doing midwifery